Results for 'Data'
Building the First AI Agent for Cancer Research
City of Hope, Monty Pal, Enrique Velazquez Villarreal, Latino, colorectal cancer, mentor, genomics, AI, artificial intelligence, multiomic
Dr. Enrique Velazquez Villarreal on AI, genomics, and why young Latinos are at the heart of his work to improve colorectal cancer research and care.
May 5th • 49 mins listen
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Labcorp, Rebecca Previs, Heidi Ko, HER2, NGS, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker, ERBB2, IHC, FISH, biomarker
What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Jun 8th • 20 mins listen
Rethinking How We Track and Treat Cancer
Labcorp, Rebecca Previs, Michelle Green, genomics, ASCO, HER2, HER3, MRD, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, ctDNA, biomarker
HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.
Jul 13th • 19 mins listen
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
Labcorp, Rebecca Previs, Ken Schlosser, biomarker, lung cancer, ALK+, advocacy, precision
Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.
Jul 31st • 23 mins listen
Movement as Medicine: The Science Reshaping Oncology
City of Hope, Monty Pal, Lee Jones, movement, exercise, holistic
In this episode of "On the Edge of Breakthrough: Voices of Cancer Research," host Dr. Monty Pal welcomes Dr. Lee Jones, Head of the Exercise Oncology Program in the Department of Medicine at City of Hope, to discuss how exercise science is helping reshape cancer treatment and care. Dr. Jones shares …
Oct 27th • 56 mins listen
How Cross-Functional Teams Reshape Cancer Care
Jay Fine, Preclinical Research, Early Stage
In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.
Feb 17th • 23 mins listen
Aspiring MSL Insight: Do You Have a Back-Pocket Presentation?
If you’re an aspiring MSL, you’re probably thinking a lot about how to master the MSL interview. 🎤 The biggest part of the interview is the presentation you’ll give during the final interview. 📊 One way to really shine on this very important element of the evaluation process …
Jul 22nd • 3 mins listen
Aspiring MSL Insight: When to Present on the Interviewing Company's Product
Aspiring MSL Insight: When to Present of the Interviewing Company's Product In our last episode, insightsspoke about having a back-pocket presentation. In this installment, he presents the counter argument to that. There are times when you have to Tin-Cup it. The MSL presentation is a ma…
Jul 29th • 3 mins listen
Aspiring MSL Insight: What Types of MSL Presentations are Acceptable in a Final Interview?
Aspiring MSL Insight: What Types of MSL Presentations are Acceptable in a Final Interview? 🧑‍⚕️🎤 If you’re an Aspiring MSL, you likely realize how important the MSL presentation is during the final interview. But you may be wondering, “What type of presentation should…
Aug 9th • 3 mins listen
Aspiring MSL Insights: The Do's and Don'ts for MSL Presentations
Aspiring MSL Insights: The Do's and Don'ts for MSL Presentations In this video, Michael Pietrack shares three best practices to implement and the three pitfalls to avoid ❌ in your MSL Presentation. If you’ve been following our Aspiring MSL content, please subscribe to the channel…
Aug 21st • 3 mins listen
Season 1, Episode 18: Challenges Facing the Pharma Universe with Jack West
In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Jack West, the VP of Clinical Development at Summit Therapeutics. They discuss Jack's transition from being a practicing oncologist to working in the pharmaceutical industry, the importance of collaborations with pharm…
Sep 9th • 35 mins listen
Busting Silos: Building the Future of Oncology Drug Development
In our premiere episode, Dr. Ramin Farhood, along with Dr. Kirk Shepard, shares the origin story behind the Oncology Voice Network (OVN)—a bold vision to unite pharma, biotech, academia, and advocacy, breaking down silos that have slowed progress for years.
Jan 20th • 33 mins listen
The Importance of Networking for MSLs with Amy Misnik
MSL industry, Hematology Oncology, MSL networking, Medical Science Liaison, pharmaceutical career
Today I have Amy Misnik on the podcast. She is the Director, Medical Science Liaisons, Hematology Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson. Today she will be sharing about her role and you will be hearing our discussion about the importance of networking in the …
Mar 26th • 35 mins listen
MSL Onboarding, Training and the first 60 days with Maria Urso
MSL onboarding, MSL training, pharma career, MSL exam preparation, qualities of MSLs
In this episode, my guest is Maria Urso. Maria is the Associate Director of MSLs for Exact Sciences. We talk about MSL onboarding, training, and the first 60 days as an MSL in addition to some other things. In this episode: How Maria ended up in pharma Maria’s view on the onboard…
Mar 26th • 37 mins listen
Top 12 Attributes of a Great MSL with Vanessa Jacobsen
MSL attributes, Medical Science Liaison, MSL career tips, Janssen Oncology, MSL podcast
In this episode, my guest is Vanessa Jacobsen. Vanessa is the Strategic External Engagement Director - Janssen Oncology, US Medical Affairs. We are going to talk about the top 12 attributes of a great MSL. Key Points How to break into the industry The top 12 attributes that make a great …
Mar 27th • 36 mins listen
Emotional Intelligence and why it is important for MSLs with Jessica Freund
Emotional Intelligence for MSLs, Medical Science Liaison career, Networking in pharmaceutical industry, Evaluating emotional intelligence, MSL interview strategies
In this episode, Jessica Freund from Biogen shares her journey into the pharmaceutical industry, highlighting her transition from Sanofi and her current role. The discussion delves into the significance of emotional intelligence for Medical Science Liaisons (MSLs), exploring its definition, tea…
Apr 14th • 30 mins listen
How to Prepare a Presentation for an MSL Interview with Kathy Gann
MSL interview preparation, presentation tips, MSL director insights, interview advice, Mallinckrodt and Syneos Health
In this episode, my guest is Kathy Gann. Kathy is a former MSL director of Mallinckrodt and Syneos Health and we talk about how to prepare a presentation for an MSL interview. Great information so anyone preparing for an interview should check this out. In this episode: Expect the unexp…
Apr 21st • 32 mins listen
What's Next: Co-creating the next reality for Field Medical after a crisis with Craig Simms
Amplify Consulting Services, field medical teams, pharma leadership, medical value proposition, biotech industry insights
Today I have Craig Simms, CEO of Amplify Consulting Services and Former MSL Director of Astellas Pharma. Our topic for today is What’s Next: Co-creating the next reality for field medical teams following a global crisis. Really interesting topic, you’re going to enjoy it. Key Poi…
Apr 28th • 40 mins listen
10 Tips for a Successful MSL Interview with Sue Watson
Sue Watson, Oncology Medical Affairs, MSL Interview Tips, Janssen Pharmaceuticals, Successful MSL Interview
My guest today is Sue Watson. Sue is the Scientific Director, Oncology Medical Affairs, Janssen Pharmaceuticals, Johnson & Johnson. Our topic today is 10 Tips for a Successful MSL interview. In this episode: Who is Sue and what she’s doing Sue’s advice as candidates sta…
May 5th • 38 mins listen
How will COVID-19 affect the MSL role and what new skills may emerge as necessary to maintain value, access and future succes
Paul Ward, Oncology MSLs, AstraZeneca, MSL Society, Covid-19 impact on MSLs
My guest today is Paul Ward. He is the National Director, Oncology MSLs at AstraZeneca, and MSL Society Advisory Board Member. We will discuss how Covid-19 will affect the role of the MSL and what new skills may emerge as necessary to maintain value, access, and future success. In this epi…
May 12th • 41 mins listen